中国卒中杂志Issue(4)：289-293,5.DOI:10.3969/j.issn.1673-5765.2014.04.006
北京地区30家社区医院2010-2012年选择性5-羟色胺再摄取抑制剂使用情况分析
Analysis on the Usage of Selective Serotonin Reuptake Inhibitors in Thirty Community Hospitals in Beijing from 2010 to 2012
马昭朝 1田德蔷 1高颖昌 1赵志刚1
作者信息
- 1. 100050 北京首都医科大学附属北京天坛医院药剂科
- 折叠
摘要
Abstract
Objective To investigate the usage of selective serotonin reuptake inhibitors in 30 community hospitals in Beijing from 2010 to 2012. Methods The data of the usage of selective serotonin reuptake inhibitors in 30 community hospitals in Beijing from 2010 to 2012 were statiscally analysed. Results The doses and expense of selective serotonin re-uptake inhibitors for 30 community hospitals in Beijing from 2010 to 2012 are increasing. Those drugs are listed as follows, according to their doses and percentage: paroxetine (44.84%), citalopram (32.4%), fluoxetine (11.60%), sertraline (10.9%) and lfuvoxamine (0.1%). There are a total of 29 manufacturers involved in our study. Smith Kline, and Janssen took the big share of the market, which account for 42.40%and 14.25%, respectively. Conclusion The doses and expense of selective serotonin reuptake inhibitors for community hospitals in Beijing are increasing. The frequently used selective serotonin reuptake inhibitors are paroxetine and citalopram, and overseas-funded medicine enterprises take the majority market share.关键词
社区医院/选择性5-羟色胺再摄取抑制剂/使用/分析Key words
Community hospital/Selective serotonin reuptake inhibitors/Drug usage/Analysis引用本文复制引用
马昭朝,田德蔷,高颖昌,赵志刚..北京地区30家社区医院2010-2012年选择性5-羟色胺再摄取抑制剂使用情况分析[J].中国卒中杂志,2014,(4):289-293,5.
